Advertisement

U.S. markets close in 3 hours 52 minutes

S&P 500
4,055.55
-21.05(-0.52%)
Dow 30
33,762.09
-323.95(-0.95%)
Nasdaq
11,540.83
-43.73(-0.38%)
Russell 2000
1,926.47
-5.48(-0.28%)
Crude Oil
77.28
-1.59(-2.02%)
Gold
1,941.00
-4.30(-0.22%)

Advertisement

Prometheus Biosciences, Inc. (RXDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Visitors trend2W10W9M

109.28

-4.39

(-3.86%)

As of 12:05PM EST. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Williams %R

View all chart patterns

Performance Outlook

Previous Close	113.66
Open	113.08
Bid	108.85 x 900
Ask	109.32 x 800
Day's Range	108.45 - 114.50
52 Week Range	21.50 - 122.75
Volume	125,385
Avg. Volume	907,320

Market Cap	5.08B
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	-2.78
Earnings Date	May 13, 2021
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	148.64

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RXDX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Prometheus Biosciences, Inc.
Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Rating
Fair Value
Economic Moat
23 hours agoMorningstar

All

Zacks
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB
XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB are part of the Zacks Investment Ideas article.
Zacks
Biotech's Blockbuster Week: 3 Stocks to Watch
In a strong week for the market, biotech dominated. Today we will cover 3 promising stocks in the space.
Zacks
Wall Street Analysts Believe Prometheus Biosciences, Inc. (RXDX) Could Rally 26.51%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in Prometheus Biosciences, Inc. (RXDX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Advertisement

S&P 5004,055.55-21.05(-0.52%)

Dow 3033,762.09-323.95(-0.95%)

Nasdaq11,540.83-43.73(-0.38%)

Russell 20001,926.47-5.48(-0.28%)

Crude Oil77.28-1.59(-2.02%)

Gold1,941.00-4.30(-0.22%)

Prometheus Biosciences, Inc. (RXDX)

Chart Events

Performance Outlook

Fair Value

Related Research

Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB

Biotech's Blockbuster Week: 3 Stocks to Watch

Wall Street Analysts Believe Prometheus Biosciences, Inc. (RXDX) Could Rally 26.51%: Here's is How to Trade

S&P 500
4,055.55
-21.05(-0.52%)

Dow 30
33,762.09
-323.95(-0.95%)

Nasdaq
11,540.83
-43.73(-0.38%)

Russell 2000
1,926.47
-5.48(-0.28%)

Crude Oil
77.28
-1.59(-2.02%)

Gold
1,941.00
-4.30(-0.22%)